Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on May 2, 2025
Global IT Signs Managed Services Agreement with Alzheimer’s Los Angeles
EIN Presswire
·
May 2, 2025
Partnership Aims to Enhance Operational Efficiency and Support Mission-Driven Technology Solutions for Alzheimer’s Los Angeles LOS ANGELES, CA, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- Global IT, a top-tier provider of Managed IT Services in Los …
Mexico Bariatric Center® Introduces Innovative SASI-S Procedure: Get Sassy with SASI
EIN Presswire
·
May 2, 2025
Mexico Bariatric Center now offers the advanced Single Anastomosis Sleeve Ileal (SASI) bypass for powerful, lasting weight loss and improved metabolic health. SACRAMENTO, CA, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- Mexico Bariatric Center, a …
Fremont Pediatric Dental: Celebrating 50+ Years of 5-Star Pediatric Dentistry in Fremont, CA
EIN Presswire
·
May 2, 2025
FREMONT, CA, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- For more than 50 years, Fremont Pediatric Dental has been a pillar of excellence in children’s oral health across Bay Area. Today, Fremont Pediatric Dentistry proudly continues to provide …
USGrants.org Tracks Over $683 Million in Federal Funding for Higher Education Programs
EIN Presswire
·
May 2, 2025
USGrants.org Tracks Over $683 Million in Federal Funding for Higher Education Programs SACRAMENTO, CA, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- USGrants.org, an online resource for federal grant information in the United States, has identified …
GenBio Is excited to share how functional foods improve liver structure and function
EIN Presswire
·
May 2, 2025
Diet plays a key role in maintaining liver health ALISO VIEJO, CA, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- Functional foods improve liver structure and function Fats are an important part of the human diet as a major source of energy. Around …
New Data Highlights Soaring Rates of Teen Mental Health Challenges in California and the USA
EIN Presswire
·
May 2, 2025
Teen mental health issues in California surge; data shows urgent need for awareness and accessible adolescent treatment programs across the state. LOS ANGELES, CA, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- Recent data paints a concerning picture …
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
GlobeNewswire
·
May 2, 2025
Court will not hear cross-claim that challenges the PH-ILD indication in the tentatively approved NDA for YUTREPIA FDA can grant final approval of YUTREPIA after blocking regulatory exclusivity expires on May 23, 2025 MORRISVILLE, N.C., May 02, 2025 (GLOBE …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
Result of General Meeting
GlobeNewswire
·
May 2, 2025
May 2, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that …
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
SAN FRANCISCO, May 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for …
New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
GlobeNewswire
·
May 2, 2025
Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled, “The Time is Now: A Clinical Practice Model to Help Prevent Progression from Barrett's to EAC” FRIENDSWOOD, …
Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
GlobeNewswire
·
May 2, 2025
XI’AN, China, May 02, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, announced today that on April 29, …
Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
GlobeNewswire
·
May 2, 2025
BOCA RATON, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
May 2, 2025
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on May 1, 2025 the Company granted inducement awards to purchase up …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
May 2, 2025
FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
GlobeNewswire
·
May 2, 2025
TORONTO and HAIFA, Israel, May 02, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system …
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
GlobeNewswire
·
May 2, 2025
SAN CARLOS, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …